1. Bataini JP, Asselain B, Jaulerry C et al. A multivariate primary tumor control analysis in 465 patients treated by radical radiotherapy for cancer of tonsillar region: clinical and treatment parameters as prognostic factors. Radiother Oncol 1989; 14(4): 265–277.
2. Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992; 23(2): 457–467.
3. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27(2): 131–146.
4. Porock D, Kristjanson L. Skin reactions during radiotherapy for breast cancer: the use and impact of topical agents and dressings. Eur J Cancer Care (Engl) 1999; 8(3): 143–153.
5. Glean E, Edwards S, Faithfull S et al. Intervention for acute radiotherapy induced skin reactions in cancer patients. J Radiother Pract 2001; 2(2): 75–84.
6. Archambeau JO, Ines A, Fajardo LF. Response of the swine skin microvasculature to acute single exposures of X rays: quantification of endothelial changes. Radiat Res 1984; 98(1): 37–51.
7. Hopewell JW, Nyman J, Turesson I. Time factor for acute tissue reactions following fractionated irradiation: a balance between repopulation and enhanced radiosensitivity. Int. J Radiat Biol 2003; 79(7): 513–524.
8. Hopewell JW. Mechanisms of the action of radiation on skin and underlying tissues. In: Jammet H, Daburon F, Gerber GB et al (eds). Radiation Damage to Skin (BJR Supplement 19). London: British Institute of Radiology 1986: 39–47.
9. Hopewell JW. The skin: its structure and response to ionizing radiation. Int J Radiat Biol 1990; 57(4): 751–773.
10. Bussolino F, Wang JM, Defilippi P et al. Granulocyte and granulocyte macrophage colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989; 337(6206): 471–473.
11. Mckay IA, Leigh IM. Epidermal cytokines and there role in cutaneous wound healing. Br J Dermatol 1991; 124(6): 513–518.
12. Patni N, Patni S, Bapna A. The optimal use of granulocyte macrophage colony stimulating factor in radiation induced mucositis in head and neck squamous cell carcinoma. J Cancer Res Ther 2006; 1(3): 136–141.
13. Kannan V, Bapsy PP, Anantha N et al. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma. Int J Radiat Oncol Biol Phys 1997; 37(5): 1005–1010.
14. Gordon B, Spadinger A, Hodges E et al. Effect of granulocyte-macrophage colony stimulating factor on oral mucositis after hematopoietic stem-cell transplantation. J Clin Oncol 1994; 12(9): 1917–1922.
15. Schuchter LM, Luginbuhl WE, Meropol NJ. The current status of toxicity protectants in cancer therapy. Semin Oncol 1992; 19(6): 742–751.
16. Naylor W, Mallett J. Management of acute radiotherapy induced skin reactions: a literature review. Eur J Oncol Nurs 2011; 5(4): 221–233.
17. Sitton E. Early and late radiation-induced skin alterations. Part I: Mechanisms of skin changes. Oncol Nurs Forum 1992; 19(5): 801–807.
18. Hamilton JA. Colony stimulating factors, cytokines and monocyte macrophages some controversies. Immunol Today 1993; 14(1): 18–24.
19. Lavery BA. Skin care during radiotherapy: a survey of UK practice. Clin Oncol (R Coll Radiol) 1995; 7(3): 184–187.
20. Hejna M, Köstler WJ, Raderer M et al. Decrease of duration and symptoms in chemotherapy induced oral mucositis by topical GM-CSF: result of a prospective randomised trial. Eur J Cancer 2001; 37(16): 1994–2002.
21. Makkonen TA, Minn H, Jekunen A et al. Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in the prevention of radiation induced mucositis: a prospective randomized study. Int J Radiat Oncol Biol Phys 2000; 46(3): 523–534.
22. Sprinzl GM, Gavlan O, de Vries A et al. Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis. Eur J Cancer 2001; 37(16): 2003–2009.
23. Saarilahti K, Kanjanti M, Joensuu T et al. Comparison of granulocyte-macrophage colony stimulating factor and sucralfate mouthwashes in the prevention of radiation induced mucositis: a double-blind prospective randomized phase III study. Int J Radiat Oncol Biol Phys 2002; 54(2): 479–485.
24. Wagner W, Alfrink M, Haus U et al. Treatment of irradiation induced mucositis with growth factors (rhGM-CSF) in patients with head and neck cancer. Anticancer Res 1999; 19(1B): 799–804.
25. Berdel WE, Danhauser-Riedl S, Steinhauser G et al. Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells. Blood 1990; 73(1): 80–83.
26. Dexter M. Haemopoietic growth factors. Review of Biology and clinical potential. Macclesfield, Cheshire: Gardiner Caldwel Ltd. 1990.
27. Margolin SG, Breneman JC, Denman DL et al. Management of radiation-induced moist skin desquamation using hydrocolloid dressing. Cancer Nurs 1990; 13(2): 71–80.
28. Lobo Gajiwala A, Sharma V. Use of irradiated amnion as a biological dressing in the treatment of radiation induced ulcers. Cell Tissue Bank 2003; 4(2–4): 147–150.
29. Gollins C, Gaffney S, Slade R et al. RCT on gentian violet versus a hydrogel dressing for radiotherapy-induced moist skin desquamation. J Wound Care 2008; 17(6): 268–270.
30. Kouvaris JR, Kouloulias VE, Plataniotis GA et al. Dermatitis during radiation for vulvar carcinoma: prevention and treatment with granulocyte-macrophage colony-stimulating factor impregnated gauze. Wound Repair Regen 2001; 9(3): 187–193.
31. Throuvalis N, Antonadou D, Pulizzi M et al. Evaluation of the efficacy and safety of GM-CSF in the prophylaxis of mucositis in patients with head and neck cancer treated with radiotherapy. Eur J Cancer 1995; Suppl 5: Abstract 431.
32. McAleese JJ, Bishop KM, A’Hern R et al. Randomized phase II study of GM-CSF to reduce mucositis caused by accelerated radiotherapy of laryngeal cancer. Br J Radiol 2006; 79(943): 608–613.
33. Wells M, MacBride S. Radiation skin reactions [online]. Available from: http://www.us.elsevierhealth.com/media//us/samplechapters/9780443064869/9780443064869.pdf.